Crescent Biopharma (CBIO) Share-based Compensation (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.32% |
| Dec 31, 2025 | 138.92% |
| Sep 30, 2025 | -62.81% |
| Jun 30, 2025 | 334.50% |
| Mar 31, 2025 | 8.38% |
| Dec 31, 2024 | 1,543.48% |
| Sep 30, 2024 | -94.28% |
| Jun 30, 2024 | 1.28% |
| Mar 31, 2024 | 31.23% |
| Dec 31, 2023 | 2.31% |
| Sep 30, 2023 | 3.47% |
| Jun 30, 2023 | -1.39% |
| Mar 31, 2023 | -3.23% |
| Dec 31, 2022 | -1.62% |
| Sep 30, 2022 | -5.17% |
| Jun 30, 2022 | -10.82% |
| Mar 31, 2022 | -18.14% |
| Dec 31, 2021 | -17.02% |
| Sep 30, 2021 | 1.84% |
| Jun 30, 2021 | -3.22% |
| Mar 31, 2021 | -0.82% |
| Dec 31, 2020 | -3.71% |
| Sep 30, 2020 | -4.05% |
| Jun 30, 2020 | -3.32% |
| Mar 31, 2020 | 5.56% |
| Dec 31, 2019 | 8.76% |
| Sep 30, 2019 | 4.46% |
| Jun 30, 2019 | 9.91% |
| Mar 31, 2019 | 20.24% |
| Dec 31, 2018 | -1.82% |
| Sep 30, 2018 | 1.80% |
| Jun 30, 2018 | 3.10% |
| Mar 31, 2018 | 15.69% |
| Dec 31, 2017 | 0.22% |
| Sep 30, 2017 | -2.90% |
| Jun 30, 2017 | 17.59% |
| Mar 31, 2017 | 16.08% |
| Dec 31, 2016 | -1.80% |
| Sep 30, 2016 | -4.18% |
| Jun 30, 2016 | 6.07% |
| Mar 31, 2016 | 12.81% |
| Dec 31, 2015 | 1.90% |
| Sep 30, 2015 | 38.12% |
| Jun 30, 2015 | -22.01% |
| Mar 31, 2015 | 21.73% |
| Dec 31, 2014 | 9.25% |
| Sep 30, 2014 | 5.58% |
| Jun 30, 2014 | 43.19% |
| Mar 31, 2014 | 382.13% |
| Dec 31, 2013 | -58.88% |
| Sep 30, 2013 | 34.42% |
| Jun 30, 2013 | 1.53% |